All Updates

All Updates

icon
Filter
Earnings/results
Origin Materials Q1 2022 update: Origin plants 1 and 2 on track to be completed; increased capital budget for Origin 1 plant by 13%
Bio-based Materials
May 9, 2022
This week:
Product updates
Hexagon unveils Advanced Compensation for metal 3D printing
Additive Manufacturing
Yesterday
Funding
Eden AI raises EUR 3 million in seed funding to accelerate product development
Generative AI Infrastructure
Nov 21, 2024
M&A
Wiz acquires Dazz to expand cloud security remediation capabilities
Next-gen Cybersecurity
Nov 21, 2024
Partnerships
Immutable partners with Altura to enhance Web3 game development and marketplace solutions
Web3 Ecosystem
Nov 21, 2024
Funding
OneCell Diagnostics raises USD 16 million in Series A funding to enhance cancer diagnostics
Precision Medicine
Nov 21, 2024
Partnerships
BioLineRx and Ayrmid partner to license and commercialize APHEXDA across multiple indications
Precision Medicine
Nov 21, 2024
Product updates
SOPHiA GENETICS announces global launch of MSK-IMPACT powered with SOPHiA DDM
Precision Medicine
Nov 21, 2024
Product updates
Biofidelity launches Aspyre Clinical Test for lung cancer detection
Precision Medicine
Nov 21, 2024
Partnerships
Spendesk partners with Adyen to enhance SMB spend management with banking-as-a-service solution
Business Expense Management
Nov 21, 2024
M&A
Mews acquires Swedish RMS provider Atomize to enhance Hospitality Cloud platform
Travel Tech
Nov 21, 2024
Bio-based Materials

Bio-based Materials

May 9, 2022

Origin Materials Q1 2022 update: Origin plants 1 and 2 on track to be completed; increased capital budget for Origin 1 plant by 13%

Earnings/results

  • Origin Materials reported an adjusted EBITDA loss of USD 6.5 million in Q1 2022, which was 1.4x the loss in Q1 2021 (USD 4.6 million). However, the company generated net income of USD 7.3 million in Q1 2022 compared to a net loss of USD 53.4 million in Q1 2021, mainly due to the gain in fair value of earnout liability (+15.2 million).

  • Operating losses for the year increased 43% YoY to USD 7.5 million in Q1 2022. This was due to increases in R&D spending (+77% YoY) and general and administrative expenses (+31% YoY) during the quarter.

<ul><li>Origin Materials also reported that its signed offtake agreements and capacity reservations increased 111% since 1H 2021 to reach USD 7.4 billion. This is a more than 7x increase since the company went public in February 2021 . The company is yet to generate revenue to date.</ul>

  • The company maintains its FY2022 adjusted EBITDA loss guidance of USD 36 million but expects capital expenditure to increase to USD 175 million in FY2022 due to the increase in the capital budget for Origin 1 (+USD 15-20 million) citing inflation and supply chain constraints.

  • Key operational highlights include: 

    • On track to complete the Origin 1 and Origin 2 plants by the end of 2022 and mid-2025 respectively. During Q1 2022, the company hired additional members for the Origin 1 operations leadership team and began the hiring process for additional operations staff. Front-end design of the Origin 2 plant also began with engineering work set to begin in 2023.

<ul><li>Partnerships with 1) Mitsubishi Chemical Holdings to develop carbon-negative tire materials, 2) LVMH Beauty to develop bio-based packaging for the perfumes and cosmetics products, and 3) Minafin Group to produce high-value, bio-based chemicals on an industrial scale.</ul>

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.